Skip to main content
. 2015 Jul 9;6(3):141–146. doi: 10.1016/j.jegh.2015.06.003

Table 4.

Characteristics of source patient and schedules for follow-up after exposure to HCW.

n %
Source patient is known 108 32.7
Serologic testing of the source patient
  Hbs Ag positivity 19 17.6
  Anti HCV positivity 20 18.5
  Anti HIV positivity 4 3.7
Negative 65 60.2
Schedules for follow-up of exposed HCW
  RF 119 36.1
  V+RF 35 10.6
  V+IP+RF 8 2.4
  Antiretroviral prophylaxis+RF 3 0.9

RF: regularly follow-up V: vaccination IP: immune prophylaxis.